Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration:...

por Chang, Margaret A., Kapre, Audrey, Kaufman, Derrick, Kardatzke, David R., Rabena, Melvin, Patel, Shienal, Bobbala, Ashwini, Gune, Shamika, Fung, Anne, Wallenstein, Gene
Publicado 2022

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

por Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E
Publicado 2014

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

por Avery, Robert L., Castellarin, Alessandro A., Steinle, Nathan C., Dhoot, Dilsher S., Pieramici, Dante J., See, Robert, Couvillion, Stephen, Nasir, Ma'an A., Rabena, Melvin D., Maia, Mauricio, Van Everen, Sherri, Le, Kha, Hanley, William D.
Publicado 2017